| ID | 原文 | 译文 |
| 1017 | ⑦出现兴奋、睡眠障碍者，临时给予镇静催眠药。 | ⑦ sedative-hypnotics can be administered temporarily for patients with sleep disorder. |
| 1018 | 人工肝治疗消除细胞因子风暴 | Artificial Liver Treatment for Suppression of Cytokine Cascade |
| 1019 | 人工肝系统集成血浆置换、吸附、灌流，血液/血浆滤过等技术，用于清除炎症介质、内毒素及中小分子有毒有害物质，补充白蛋白、凝血因子等有益物质，调节水电解质、酸碱平衡；能阻断“细胞因子风暴”，纠正休克，减轻肺部炎症，改善呼吸功能；同时有助于恢复机体免疫稳态、改善体内代谢紊乱状态、有利于容量精准管理、改善肝、肾等多器官功能，以提高重型、危重型患者的救治成功率，降低病死率。 | The artificial liver support system (ALSS) can conduct plasma exchange, adsorption, per fusion, and filtration of inflammatory mediators such as endotoxins and harmful metabolic substances of small or medium molecular weight. It can also provide serum albumin, coagulation factors, balance fluid volume, electrolytes and acid-base ratio, and manifest anti-cytokine storms, shock, lung inflammation, et al. In doing so it can also help to improve multiple organ functions including the liver and kidney. Thus, it can increase treatment success and reduce the mortality of severe patients. |
| 1020 | 2.1适应证 | 2.1 Indication for ALSS |
| 1021 | ①血炎症因子（如IL-6等）浓度≥正常上限5倍，或每日上升速度≥1倍； | ① serum inflammatory indicator (such as IL-6) level rises to ≥ 5 ULN, or rising rate is ≥1 time per day; |
| 1022 | ②肺部影像学快速进展，CT或X线提示肺受累百分比每天进展10%或以上； | ② involved area of pulmonary C T or X-ray images ≥10% progression per day; |
| 1023 | ③基础疾病需要人工肝治疗患者； | ③ artificial liver support system is required for the treatment of underlying diseases. |
| 1024 | 符合①+②的患者，或符合③的患者。 | Patients meeting ① + ②, or patients meeting ③. |
| 1025 | 2.2相对禁忌证 | 2.2 Contraindications |
| 1026 | 在危重型患者抢救中，无绝对禁忌证，但出现以下情况须谨慎使用： | There is no absolute contraindication in the treatment of critically ill patients. However, ALSS should be avoided in the following situations: |